These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16888236)

  • 1. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
    Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
    Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system.
    Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S
    Am J Pathol; 2008 Dec; 173(6):1911-8. PubMed ID: 18974301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
    Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
    Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
    Kasahara Y; Taguchi A; Uno H; Nakano A; Nakagomi T; Hirose H; Stern DM; Matsuyama T
    Brain Res; 2010 Jun; 1340():70-80. PubMed ID: 20388500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
    Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S
    Am J Pathol; 2007 Jun; 170(6):2149-58. PubMed ID: 17525280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
    Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M
    Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARĪ³ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells.
    Cianchetti S; Del Fiorentino A; Colognato R; Di Stefano R; Franzoni F; Pedrinelli R
    Atherosclerosis; 2008 May; 198(1):22-8. PubMed ID: 17950296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
    Kurihara T; Ozawa Y; Shinoda K; Nagai N; Inoue M; Oike Y; Tsubota K; Ishida S; Okano H
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5545-52. PubMed ID: 17122147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
    Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
    Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
    Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.